N32-53681-37427

3 vaccinations 5 coded responses 13 check-ins 4 free-text entries 6 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 468 / IN
Registered: 2021-04-05

Relationship: Self
Race: Multiracial
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-15
Dose 1 — Pfizer-BioNTech
2021-04-05
Registered in v-safe
2021-04-12
Dose 2 — Pfizer-BioNTech
2021-04-12
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-04-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-04-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Nausea, Vomiting · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2021-04-15
Report sent to call center — days 1–6 daily, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness, Nausea

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-19
Health check-in — day 7, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-10-11
Survey response — 6 months, dose 2
MedDRA: Pregnancy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Pregnancy

MedDRA releases: 2024-11 · check-in free text available
2021-10-11
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2021-10-13
Call 2 — Left Voicemail
2022-04-13
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-04-25
Dose 3 — Pfizer-BioNTech
2022-04-25
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2022-05-23
Survey response — day 28, dose 3
MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: epstein barres flair

MedDRA releases: 2024-11 · check-in free text available
2022-05-23
Report sent to call center — day 28, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-05-24
Call 1 — Left Voicemail
2022-07-25
Survey response — 3 months, dose 3
MedDRA: Brain neoplasm — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: brain tumor

MedDRA releases: 2024-11 · check-in free text available
2022-07-25
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-07-26
Call 1 — Left Voicemail
2022-07-26
Call 1 — Left Voicemail
2022-07-26
Call 2 — Left Voicemail
2022-07-26
Call 1 — Left Voicemail
2022-10-26
Survey response — 6 months, dose 3
MedDRA: Kidney infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: kidney infection

MedDRA releases: 2024-11 · check-in free text available
2022-10-26
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-10-27
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-10-27
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-10-27
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-10-27
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-10-27
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-04-25
Survey response — 12 months, dose 3
MedDRA: Anaemia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

MedDRA releases: 2024-11
2023-04-25
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
2023-04-26
Call successful
Completed over the phone

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-15	Pfizer-BioNTech
2	2021-04-12	Pfizer-BioNTech
3	2022-04-25	Pfizer-BioNTech	No

Call center

6 call center cases

6 successful

VAERS report filed, before or during a call: 1

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 10 — 6 months, dose 2

2021-10-11

Symptoms: Pregnancy

Release 11 — day 28, dose 3

2022-05-23

Symptoms: epstein barres flair

Release 12 — 3 months, dose 3

2022-07-25

Symptoms: brain tumor

Release 12 — 6 months, dose 3

2022-10-26

Symptoms: kidney infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anaemia	·	·	✓
SD	Brain neoplasm	·	·	✓
SD	Condition aggravated	·	·	✓
SD	Kidney infection	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release